172 related articles for article (PubMed ID: 26166437)
1. Maintaining drug supply to Greece in an uncertain future.
Burki TK
Lancet Oncol; 2015 Aug; 16(8):e382. PubMed ID: 26166437
[No Abstract] [Full Text] [Related]
2. Greek economic crisis and health care reforms: correcting the wrong prescription.
Niakas D
Int J Health Serv; 2013; 43(4):597-602. PubMed ID: 24397229
[TBL] [Abstract][Full Text] [Related]
3. Pressure mounts on drug supplies in Greece.
Photopoulos J
BMJ; 2015 Jul; 351():h3804. PubMed ID: 26169533
[No Abstract] [Full Text] [Related]
4. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
Tetteh E
Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
[No Abstract] [Full Text] [Related]
5. The Health Impact Fund: incentives for improving access to medicines.
Banerjee A; Hollis A; Pogge T
Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
[No Abstract] [Full Text] [Related]
6. The storm's aftermath.
Meyer CR
Minn Med; 2012 Feb; 95(2):4. PubMed ID: 22474883
[No Abstract] [Full Text] [Related]
7. Research on green supply chain coordination strategy for uncertain market demand.
Cao J; Chen Y; Lu B; Tong C; Zhou G
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):687-92. PubMed ID: 25796145
[TBL] [Abstract][Full Text] [Related]
8. 5 years of austerity takes its toll on Greek health care.
Karamanoli E
Lancet; 2015 Dec; 386(10010):2239-40. PubMed ID: 26681280
[No Abstract] [Full Text] [Related]
9. Health under austerity in Greece.
Burki T
Lancet; 2018 Feb; 391(10120):525-526. PubMed ID: 29617228
[No Abstract] [Full Text] [Related]
10. Health spending projections through 2018: recession effects add uncertainty to the outlook.
Sisko A; Truffer C; Smith S; Keehan S; Cylus J; Poisal JA; Clemens MK; Lizonitz J
Health Aff (Millwood); 2009; 28(2):w346-57. PubMed ID: 19240055
[TBL] [Abstract][Full Text] [Related]
11. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Buckely M
Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
[No Abstract] [Full Text] [Related]
12. Health care in America: sustainable path or collision course?
Pentecost MJ
J Am Coll Radiol; 2005 Feb; 2(2):114-7. PubMed ID: 17411778
[No Abstract] [Full Text] [Related]
13. Oncology drug market worth predicted to increase.
Burki TK
Lancet Oncol; 2015 Jan; 16(1):e10. PubMed ID: 25638545
[No Abstract] [Full Text] [Related]
14. Refugee crisis in Greece: healthcare and integration as current challenges.
Moris D; Kousoulis A
Perspect Public Health; 2017 Nov; 137(6):309-310. PubMed ID: 29082846
[No Abstract] [Full Text] [Related]
15. Illegal importation of pharmaceuticals: implications for community pharmacy and public health.
Fuller C
Manag Care; 2004 Mar; 13(3 Suppl):34-5. PubMed ID: 15074169
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: cost savings.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
[No Abstract] [Full Text] [Related]
17. Economic crisis and counter-reform of universal health care systems: Spanish case.
Fortes PA; Carvalho RR; Louvison MC
Rev Saude Publica; 2015; 49():34. PubMed ID: 26083942
[TBL] [Abstract][Full Text] [Related]
18. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
19. Access to medicines is not the business of the pharma industry.
Brown PJ
J Int Assoc Physicians AIDS Care (Chic); 2002; 1(1):9-11; discussion 12-4. PubMed ID: 12942664
[No Abstract] [Full Text] [Related]
20. Stories from a struggling economy.
Mettner J
Minn Med; 2012 Feb; 95(2):16-21. PubMed ID: 22474887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
